Autoantibodies to other potentially relevant cytokines in the immune response to TB, such as interleukin (IL)-12 or granulocyte-macrophage colony-stimulating factor (GM-CSF), have so far only rarely been assessed in individual patients in case reports [11,15,16,17], but never systematically in larger cohorts of patients. The gene discussed is CSF2; the disease is tuberculosis.